Ocular Therapeutix, Inc. (OCUL)

Healthcare · Biotechnology · NASDAQ

Ocular Therapeutix, Inc. (OCUL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.02B and a free-cash-flow yield of -12.6%. Over the most recent reported fiscal year, revenue declined 18.5%.

Market cap	$2.02B
Trailing P/E	—
FCF yield	-12.6%
Revenue growth (YoY)	-18.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live OCUL data on Nama Insights →